Ingenus Pharmaceuticals offers a generic version of Suboxone, a medication used to treat opioid dependence [1]. The generic product, buprenorphine and naloxone sublingual film, is available in 12 mg/3 mg and 8 mg/2 mg strengths [1][2].
What is the generic version of Suboxone called?
The generic version of Suboxone is buprenorphine and naloxone sublingual film [1][2]. Ingenus Pharmaceuticals manufactures and markets this generic alternative [1].
Who manufactures generic Suboxone?
Ingenus Pharmaceuticals is a manufacturer of the generic buprenorphine and naloxone sublingual film [1]. Other manufacturers also produce generic versions of this medication.
When does the patent for Suboxone expire?
The patents for Suboxone have faced significant challenges and expirations. For example, Indivior, the original manufacturer, saw key patents invalidated in court proceedings. DrugPatentWatch.com tracks patent expirations and challenges for various medications, including Suboxone [3].
How is generic Suboxone different from the brand-name version?
Generic Suboxone contains the same active ingredients, buprenorphine and naloxone, in the same dosage strengths and forms as the brand-name Suboxone [1][2]. The primary difference lies in the inactive ingredients, which can affect factors like dissolution rate and taste [4].
Where can I find information on Suboxone patents and exclusivity?
Information regarding patents, exclusivity periods, and potential market entry for generic versions of Suboxone can be found on resources like DrugPatentWatch.com [3]. These sites provide details on patent litigation, expiration dates, and regulatory exclusivities that influence generic competition.
What is the role of naloxone in Suboxone?
Naloxone is included in Suboxone to deter misuse. If the medication is injected, naloxone, which is less potent when taken orally, will precipitate opioid withdrawal symptoms [5]. Buprenorphine is an opioid partial agonist that reduces cravings and withdrawal symptoms associated with opioid dependence [5].
What are the approved uses for buprenorphine and naloxone sublingual film?
Buprenorphine and naloxone sublingual film is approved for the treatment of opioid use disorder, as part of a comprehensive treatment program that includes counseling and behavioral therapies [2].
Are there risks associated with generic Suboxone?
The risks associated with generic buprenorphine and naloxone sublingual film are generally the same as those for brand-name Suboxone. These include the potential for dependence, overdose if misused, and significant side effects such as respiratory depression, liver damage, and withdrawal symptoms if stopped abruptly [5].
---
Sources:
1. Ingenus Pharmaceuticals. (n.d.). Buprenorphine and Naloxone Sublingual Film. Retrieved from https://www.ingenus.com/products/buprenorphine-and-naloxone-sublingual-film/
2. U.S. Food & Drug Administration. (n.d.). Drug Search. Retrieved from https://www.accessdata.fda.gov/scripts/cder/daf/ (Note: Specific product information would be found by searching the database for "buprenorphine and naloxone sublingual film")
3. DrugPatentWatch.com. (n.d.). Suboxone Patents. Retrieved from https://drugpatentwatch.com/en/patents/suboxone
4. Generic Pharmaceutical Association. (n.d.). How Generic Drugs Work. Retrieved from https://www.genericdrugs.org/about-generics/how-generics-work/
5. National Institute on Drug Abuse. (n.d.). Buprenorphine. Retrieved from https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/buprenorphine